SCHEMBL24310386

SCHEMBL24310386

CC(C)CCc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccc(Cl)cc2)c1C(F)(F)F

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310387 0.89 CTSC (0.35) —
SCHEMBL24309841 0.88 PTK2 (0.34) —
SCHEMBL24310812 0.86 — —
SCHEMBL24310647 0.86 HTR1A (0.33) KDM4ECYP1A2CYP2C9CYP2C19ATM
SCHEMBL24310169 0.81 FLT4 (0.31) —
SCHEMBL24309610 0.80 — —
SCHEMBL26808497 0.76 CTSC (0.34) —
SCHEMBL29566490 0.76 CTSC (0.34) —
SCHEMBL24310416 0.75 USP1 (0.32) —
SCHEMBL29566808 0.75 DAPK1 (0.36) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback